Axogen [AXGN] vs Stryker [SYK] Detailed Stock Comparison

Axogen Inc.

NASDAQ
Loading...

Stryker Corporation

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: Axogen Inc. wins in 4 metrics, Stryker Corporation wins in 15 metrics, with 0 ties. Stryker Corporation appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Axogen Inc. Stryker Corporation Better
P/E Ratio (TTM) -110.18 39.21 Stryker Corporation
Price-to-Book Ratio 13.15 5.62 Stryker Corporation
Debt-to-Equity Ratio 55.50 72.97 Axogen Inc.
PEG Ratio 0.04 0.72 Axogen Inc.
EV/EBITDA -2,165.44 19.90 Stryker Corporation
Profit Margin (TTM) -6.97% 12.92% Stryker Corporation
Operating Margin (TTM) -16.31% 27.24% Stryker Corporation
EBITDA Margin (TTM) N/A 27.24% N/A
Return on Equity -13.49% 15.08% Stryker Corporation
Return on Assets (TTM) -2.31% 7.92% Stryker Corporation
Free Cash Flow (TTM) $-4.78M $4.28B Stryker Corporation
Dividend Yield N/A 0.97% N/A
1-Year Return 341.03% -17.25% Axogen Inc.
Price-to-Sales Ratio (TTM) 8.27 5.02 Stryker Corporation
Enterprise Value $1.89B $138.30B Stryker Corporation
EV/Revenue Ratio 8.40 5.51 Stryker Corporation
Gross Profit Margin (TTM) 74.13% 64.54% Axogen Inc.
Revenue per Share (TTM) $5 $66 Stryker Corporation
Earnings per Share (Diluted) $-0.34 $8.40 Stryker Corporation
Beta (Stock Volatility) 0.98 0.93 Stryker Corporation
Short % of Float 6.92% 1.20% Stryker Corporation

Axogen Inc. vs Stryker Corporation Stock Performance Analysis

Loading Price Chart...

AXGN
SYK

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Axogen Inc.1.72%5.50%6.71%33.19%46.88%41.10%
Stryker Corporation-1.36%2.13%0.38%-11.91%-13.33%-11.56%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Axogen Inc.341.03%367.90%106.53%628.81%1,769.57%12,185.71%
Stryker Corporation-17.25%6.06%22.47%172.95%440.98%592.85%

Performance & Financial Health Analysis: Axogen Inc. vs Stryker Corporation

MetricAXGNSYK
Market Information
Market Cap i$1.94B$126.25B
Market Cap CategorySmall capLarge cap
10 Day Avg. Volume i1,245,2381,881,406
90 Day Avg. Volume i1,068,3532,161,139
Last Close$43.74$307.94
52 Week Range$9.22 - $45.83$281.00 - $404.87
% from 52W High-4.56%-23.94%
All-Time High$56.85 (Jul 23, 2018)$406.19 (Jan 27, 2025)
% from All-Time High-23.06%-24.19%
Growth Metrics
Quarterly Revenue Growth0.21%0.11%
Quarterly Earnings Growth0.21%0.56%
Financial Health
Profit Margin (TTM) i-0.07%0.13%
Operating Margin (TTM) i-0.16%0.27%
Return on Equity (TTM) i-0.13%0.15%
Debt to Equity (MRQ) i55.5072.97
Cash & Liquidity
Book Value per Share (MRQ)$2.73$58.61
Cash per Share (MRQ)$0.80$10.71
Operating Cash Flow (TTM) i$812,000$5.04B
Levered Free Cash Flow (TTM) i$3.58M$4.17B
Dividends
Last 12-Month Dividend Yield iN/A0.97%
Last 12-Month Dividend i$0.00$3.40

Valuation & Enterprise Metrics Analysis: Axogen Inc. vs Stryker Corporation

MetricAXGN (Apr 24, 2026)SYK (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i-110.1839.21
Forward P/E i47.3119.67
PEG Ratio i0.040.72
Price to Sales (TTM) i8.275.02
Price to Book (MRQ) i13.155.62
Market Capitalization
Market Capitalization i$1.94B$126.25B
Enterprise Value i$1.89B$138.30B
Enterprise Value Metrics
Enterprise to Revenue i8.405.51
Enterprise to EBITDA i-2,165.4419.90
Risk & Other Metrics
Beta i0.980.93
Book Value per Share (MRQ) i$2.73$58.61

Financial Statements Comparison: Axogen Inc. vs Stryker Corporation

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricAXGN (2025)SYK (2025)
Revenue/Sales i225.21M25.12B
Cost of Goods Sold i57.86M9.05B
COGS % of Revenue i25.7%36.0%
Gross Profit i167.35M16.07B
Gross Margin i74.3%64.0%
Research & Development i32.89M1.62B
Operating Income (EBIT) i-7.85M5.06B
Operating Margin i-3.5%20.1%
EBITDA i826,0006.48B
EBITDA Margin i0.4%25.8%
Pre-Tax Income i-15.70M4.51B
Pre-Tax Income % of Revenue i-7.0%18.0%
Income Tax iN/A1.27B
Income Tax % of Revenue i0.0%5.0%
Net Income (Profit) i-15.70M3.25B
Profit Margin i-7.0%12.9%

Balance Sheet & Liquidity Metrics

MetricAXGN (2025)SYK (2025)
Cash & Equivalents i35.55M4.01B
Total Current Assets i120.42M14.76B
Total Current Assets % of Revenue i53.5%58.7%
Total Current Liabilities i23.56M7.79B
Total Current Liabilities % of Revenue i10.5%31.0%
Long-Term Debt i65.26M14.86B
Long-Term Debt % of Revenue i29.0%59.2%
Total Shareholders Equity i128.85M22.42B
Retained Earnings i-306.96M20.47B
Retained Earnings % of Revenue i-136.3%81.5%
Property, Plant & Equipment i29.38M1.79B

Cash Flow Statement Comparison

MetricAXGN (2025)SYK (2025)
Operating Cash Flow i10.26M4.70B
Operating Cash Flow % of Revenue i4.6%18.7%
Capital Expenditures i-3.75M-761.00M
Free Cash Flow i-4.78M4.28B
FCF Margin i-2.1%17.1%
Debt Repayment i-32,000-1.40B
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricAXGNSYK
Shares Short i3.50M4.42M
Short Ratio i4.041.95
Short % of Float i6.92%1.20%
Shares Outstanding i47.20M382.50M
Float Shares i50.75M346.55M
% Held by Insiders i2.12%5.37%
% Held by Institutions i88.11%82.09%
% Held by Public i9.77%12.54%

Dividend Analysis & Yield Comparison: Axogen Inc. vs Stryker Corporation

MetricAXGNSYK
Last 12-Month Dividend i$0.00$3.40
Last 12-Month Dividend Yield iN/A0.97%
3-Year Avg Annual Dividend i$0.00$3.23
3-Year Avg Dividend Yield iN/A0.24%
3-Year Total Dividends i$0.00$9.69
Ex-Dividend DateN/ADec 31, 2025